Intermittently delivered IV medication and pH: reevaluating the evidence

Lisa A Gorski1, Mary E Hagle, Steve Bierman

  • 1Wheaton Franciscan Home Health & Hospice, Milwaukee, Wisconsin (Ms Gorski); Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin (Dr Hagle); University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (Dr Hagle); and Access Scientific LLC, San Diego, California (Dr Bierman). Lisa A. Gorski, MS, RN, CRNI®, HHCNS-BC, FAAN, has been a clinical nurse specialist at Wheaton Franciscan Home Health and Hospice in Milwaukee, Wisconsin, since 1985. She served as INS' president from 2007 to 2008 and is the chairperson of INS Standards of Practice Committee. Mary E. Hagle, PhD, RN, FAAN, worked as a clinical nurse specialist in oncology for many years, then as a clinical researcher for the past 14 years. Currently, she is a nurse scientist with Clement J. Zablocki Veterans Affairs Medical Center in Milwaukee and an adjunct clinical assistant professor at the University of Wisconsin-Milwaukee. She is president of the Southeast Wisconsin Chapter of INS and a member of INS' Standards of Practice Committee. Steve Bierman, MD, who is board certified in emergency medicine, family practice, and medical hypnosis, was an emergency physician for 18 years before founding Venetec International in 2001. He is currently founder and chief medical officer of Access Scientific, LLC, in San Diego, California.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
398
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
172
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
508
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
251
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
367
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
382